Hi All,
I love a good spreadsheet so was going to look at the NPV's associatedwith ResAppDx so I could do some sensitivities around changed input parameters both in peak year sales and revenue projections.
In setting this up I came across the following assumptions adopted byAcuity in the financial modelling, particularly around COGS and SG&A (I hadto look up what these mean) which equate to 55% of expectedrevenues.
Over the life of the economic modelling period (to 2041) this has apretty significant impact on cashflows and hence I am assuming valuations and has been applied to all 4 ofour products.
Cheers
Information from Acuity Report
COGs and SG&A definitions from a google search:
Impacts on ResAppDx cashflows (Note that I've initially adopted a discount rate of 8% with no CPI.)
If I was toassume $10M/ annum COGS/ SG&A associated with ResAppDx instead of 55% of revenue, this has asignificant impact on cashflows and NPV.
- Forums
- ASX - By Stock
- Estimating NPV of ResAppDx
Hi All,I love a good spreadsheet so was going to look at the...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online